Atorvastatin is metabolised by CYP3A4, and drugdrug interactions with inhibitors of this system have been demonstrated [24]
da Silva LE, de Oliveira MP, da Silva MR, Abel Jda, Tartari S, de Costa G et al
Patients receiving the 2.4 mg weekly dose (Wegovy) for weight management may experience more pronounced digestive effects compared to those on lower doses used for diabetes management
[8] [1] Rotating injection sites with each dose, as recommended by the American Association of Clinical Endocrinology (AACE) and the American Diabetes Association, helps prevent lipohypertrophy (fatty lumps) and reduces localized tenderness from repeated injections in the same area
100 g Indications: It improves muscular mass increase (weight) and thus, the animals athletic performance
It comes down to personal preference